Table 2.
The comparation between the CONUT score and patients’ characteristics and laboratory parameters.
| CONUT score | p | |
|---|---|---|
| Median (min–max) | ||
| Age <65 | 1 (0–9) | p = 0.001 |
| Age≥65 | 2 (0–11) | |
| Sex (female) | 1 (0–11) | p = 0.667 |
| Sex (male) | 1 (0–10) | |
| ECOG<1 | 1 (0–8) | p = 0.001 |
| ECOG≥1 | 2 (0–11) | |
| LDH normal | 1 (0–10) | p = 0.001 |
| LDH>normal | 2 (0–11) | |
| Bone marrow involvement (-) | 1 (0–11) | p = 0.001 |
| Bone marrow involvement (+) | 3 (0–7) | |
| Extranodal disease (-) | 1 (0–9) | p = 0.001 |
| Extranodal disease (+) | 2 (0–11) | |
| Stage (IA-IIB) | 0 (0–11) | p = 0.001 |
| Stage (IIIA-IVB) | 2 (0–9) | |
| IPI (low,low intermediate) | 0 (0–8) | p = 0.001 |
| IPI (high intermediate,high) | 3 (0–11) | |
| Progressive disease (-) | 1 (0–9) | p = 0.001 |
| Progressive disease (+) | 2.5 (0–11) | |
| RCHOP chemotherapy | 1 (0–11) | p = 0.153 |
| RCHOP-mini chemotherapy | 1 (0–10) | |
| DA REPOCH chemotherapy | 2 (0–9) |